Resistant Bacteria Bring New Challenges to Anti-Infectives Market

ROCKVILLE, MD, Nov 02 (MARKET WIRE) --
MarketResearch.com has announced the addition of Kalorama Information's
new report "The Worldwide Market for Anti-Infectives (Antifungals,
Antibacterials and Antivirals)," to their collection of Healthcare market
reports. For more information, visit
http://www.marketresearch.com/redirect.asp?progid=67618&productid=2435380

The anti-infective market is at a critical juncture. For the past 60
years, antibiotic drugs have turned bacterial infections into treatable
conditions rather than the life-threatening scourges they once were. But
the effectiveness of many antibiotics is waning dramatically, as more and
more types of bacteria become resistant to them.

This Kalorama Information The World Market for Anti-Infectives considers
the anti-infective drug market as it faces challenges with resistance and
generic competition. The report focuses on three key segments of
treatment:

-- Antifungals (Allylamines, Azoles,Polyene Macrolides and Other
Antifungals)
-- Antibacterials (Cephalosporins, Macrolides, Penicillins, Quinolones,
Sulfonamides, Tetracyclines, Carbopenems, Miscellaneous)
-- Antivirals (Nucleoside Analogs, Transcriptase Inhibitors, DNA
Polymerase Inhibitors, Protease Inhibitors)

For each category and each subsegment, current market and forecast is
provided. The report covers both currently marketed and late stage
development products. Revenues for each segment were generated using
dollar sales for each product.

The report includes statistical information for infections by type
worldwide, with special emphasis on the U.S. and Europe. As part of its
coverage the report provides:

-- Overview
-- Description of Products on the Market
-- Review of Products in Late Stage Development
-- Market Estimates and Forecasts
-- Competitive Analysis of Leading Providers
-- Regional Breakdown of Antifungal, Antibacterial and Antiviral Market
(US, Europe and Asia)
-- Market Share of Antifungal, Antibacterial and Antiviral Market

The information for this report was gathered using both primary and
secondary research including comprehensive research of secondary sources
such as company literature, databases, investment reports, and medical and
business journals focused on the anti-infective industry. Telephone
interviews and email correspondence were the primary method of gathering
information. For the purpose of this study Kalorama Information conducted
interviews with key industry officials, consultants, health care
providers, and government personnel. These sources were the primary basis
in gathering information specifically relating to revenue and market
share data presented in this report. Specific interviews with
pharmaceutical company representatives included marketing directors,
division managers, and product representatives.

For more information, visit
http://www.marketresearch.com/redirect.asp?progid=67618&productid=2435380

Contact:
Gregg Kellett
MarketResearch.com
gkellett@marketresearch.com
240.747.3008

Copyright 2009, Market Wire, All rights reserved.

-0-